NCT04559048View on ClinicalTrials.gov

Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

March 15, 2024

Study Completion Date

June 30, 2024

Conditions

Chronic PainLiver Transplantation

Interventions

DRUG

FK506

FK506 (tacrolimus), a calcineurin inhibitor, is widely used as an immunosuppressant to lower the risk of organ rejection after organ transplantation

Trial Locations (1)

063000

RECRUITING

The Second Hospital of Tangshan, Tangshan

All Listed Sponsors

collaborator

Chinese PLA General Hospital

OTHER

lead

The Second Hospital of Tangshan

OTHER

NCT04559048 - Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients | Biotech Hunter | Biotech Hunter